Piper Sandler keeps USD 50.50 target for Monster Beverage stock

Published on 10/21/2026 at 10:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Piper Sandler keeps Overweight and a USD 50.50 target. Monster Beverage stock costs EUR 41.79 on October 21, 2026, 2.63 percent above Xetra close.

Analyst view and quarterly scale

Piper Sandler maintained an Overweight rating and a USD 50.50 target on October 19, 2026.
Monster Beverage reported USD 2.54 billion in second-quarter 2026 revenue.
Monster Beverage stock traded at EUR 41.79 at 10:42 a.m. CEST at Lang & Schwarz on October 21, 2026, 2.63 percent above the Xetra close of October 20, 2026.

Editorialfoto eines Börsenparketts mit Händlern und Konsumgüter-Kursdiagrammen auf Bildschirmen — Editorial-Aufnahme eines Börsenparketts mit Konsumgüter-Charts repräsentiert den Börsenhandel mit Monster Beverage, ISIN US61174X1090, Illustration mit AI erstellt.

Monster Beverage (US61174X1090) traded at EUR 41.79 at Lang & Schwarz on October 21, 2026, at 10:42 a.m. CEST, 2.63 percent above the October 20 Xetra close of EUR 40.72. Piper Sandler maintained an Overweight rating and a USD 50.50 price target on October 19, 2026, according to Investing.com.

Growth supports the analyst case

The latest reported quarter gives that view a measurable foundation. For the quarter ended June 30, 2026, Monster Beverage generated USD 2.54 billion in revenue and USD 584.54 million in net income, according to Markets Insider. Revenue was USD 2.11 billion in the year-earlier quarter, making the reported increase 20.20 percent.

The same report put quarterly earnings per share at USD 0.60 against a USD 0.58 consensus estimate. That comparison matters because the stock's valuation debate now rests on whether strong sales growth can translate into durable earnings expansion.

What do the targets imply?

The analyst picture is not uniform. Borse Express reported that UBS cut its target from USD 53.00 to USD 49.00 while retaining a neutral rating. Piper Sandler's USD 50.50 target therefore sits above UBS's revised view, but both are below the wider consensus target of USD 74.07 cited in recent market coverage.

Three dates frame the story

On June 30, 2026, Monster Beverage posted USD 2.54 billion in quarterly revenue. On October 15, 2026, UBS was reported to have reduced its target to USD 49.00. On October 19, 2026, Piper Sandler retained Overweight with a USD 50.50 target, the latest of the three dated developments.

Next product and results dates

The next quarterly results are scheduled for October 29, 2026, as indicated in recent company coverage. Monster Beverage's planned Protein Energy line is scheduled for March 2027, according to Borse Express.

Stock holds above the Xetra close

The price reaction gives the analyst debate a live market setting, while the latest revenue figure supplies the operating counterweight. Monster Beverage is listed on Nasdaq under MNST and operates in the non-alcoholic beverages industry.

Monster Beverage stock was trading at EUR 41.79 at Lang & Schwarz on October 21, 2026, at 10:42 a.m. CEST, 2.63 percent above the Xetra close of October 20, 2026, at EUR 40.72. The further course of trading is shown by the continuously updated real-time quote of Monster Beverage stock.